Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Burkitt Lymphoma × Transplantation Conditioning × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hematologic Neoplasms 2 Graft vs Host Disease 2 Stomatitis 1 Myelodysplastic Syndromes 1 Leukemia 1 Burkitt Lymphoma 1

Interventions

Cyclophosphamide 107 Peripheral Blood Stem Cell Transplantation 53 Filgrastim 53 Etoposide 53 Rituximab 49 Radiotherapy 43 Vincristine 42 fludarabine phosphate 41 Methotrexate 38 Cytarabine 38 Doxorubicin 37 Prednisone 30 Cyclosporine 30 Whole-Body Irradiation 29 Mycophenolic Acid 28 Busulfan 25 Melphalan 24 Antilymphocyte Serum 23 Tacrolimus 22 Dexamethasone 22 Methylprednisolone 18 Carmustine 16 Leucovorin 15 Granulocyte Colony-Stimulating Factor 15 Ifosfamide 13 Calcium Dobesilate 13 Psychiatric Rehabilitation 11 Cord Blood Stem Cell Transplantation 11 merphos 10 Thiotepa 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01516593 2022-08-04

CARMEN

IRCCS San Raffaele

Phase 2 Completed

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡